Teva Opposes Switching Asthma Drugs, Oral Contraceptives
This article was originally published in The Tan Sheet
Executive Summary
The firm’s opposition to allowing innovative switches for asthma drugs and oral contraceptives focuses on safety and consumers’ ability to self-select and manage their allergies or reproductive status, but maintains that Plan B One-Step and other emergency contraceptives are appropriate for full OTC status.